November 15, 2021 – Medtronic plc (Dublin, Ireland) announced four executive appointments:
- Bob Hopkins, head of global strategy, effective today.
- Mei Jiang, new global digital innovation leader, effective today.
- Harry “Skip” Kiil, President of the Cranial and Spinal Technologies (CST) Operating Unit, effective Jan. 4, 2022.
- Mira Sahney, President of the Pelvic Health Operating Unit, effective Dec. 6, 2021.
Hopkins comes from Bank of America Merrill Lynch, where he has served as Managing Director since 2008, covering the medical technology industry, including Medtronic. As head of global strategy, Hopkins will partner with Medtronic senior leadership in the areas of strategy, business development, capital deployment and investor communication.
Jiang will join Medtronic from Iron Mountain, where she served as SVP, Global Head of Innovation, Product & Solutions. As head of global digital innovation, Jiang will work with leaders across the organization to test, expand, and accelerate Medtronic’s data, digitization, and AI strategies, globally. This work includes using data and AI to enhance internal processes, as well as establishing new business models leveraging existing capabilities and technologies. She’ll transform the company’s core markets and businesses using the insights of data and AI, as well as establish enterprise-wide capabilities and resources needed to support this transformation.
Kiil will join Medtronic from Smith+Nephew, where he was President of the Global Orthopaedics business, responsible for the company’s reconstructive arthroplasty, robotics, trauma, and extremities businesses. In his new role, Kiil will be responsible for driving innovation and delivering therapies to markets around the world more quickly and effectively and cultivating a strong culture within Cranial and Spinal Technologies.
Sahney joins Medtronic from Hyalex Orthopaedics, a start-up medical device company, where she has served as CEO and a member of the Board of Directors since 2017. At Medtronic, Sahney will leverage her deep background in mergers and acquisitions, product marketing, and commercial strategy to lead the Pelvic Health operating unit into the increasingly competitive future of the incontinence market. In her new role, Sahney will be responsible for driving innovation and expanding access to more patients around the world, while cultivating a strong culture within Pelvic Health.